Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease

References

1. 1.↵
   1. Acosta-Cabronero J,
   2. Cardenas-Blanco A,
   3. Betts MJ, et al

   . The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease. Brain 2017;140:118–31 doi:10.1093/brain/aww278 pmid:27836833

   CrossRefPubMed
2. 2.↵
   1. An H,
   2. Zeng X,
   3. Niu T, et al

   . Quantifying iron deposition within the substantia nigra of Parkinson’s disease by quantitative susceptibility mapping. J Neurol Sci 2018;386:46–52 doi:10.1016/j.jns.2018.01.008 pmid:29406966

   CrossRefPubMed
3. 3.↵
   1. Ghassaban K,
   2. He N,
   3. Sethi SK, et al

   . Regional high iron in the substantia nigra differentiates Parkinson’s disease patients from healthy controls. Front Aging Neurosci 2019;11:106 doi:10.3389/fnagi.2019.00106 pmid:31191294

   CrossRefPubMed
4. 4.↵
   1. Langkammer C,
   2. Schweser F,
   3. Krebs N, et al

   . Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012;62:1593–99 doi:10.1016/j.neuroimage.2012.05.049 pmid:22634862

   CrossRefPubMed
5. 5.↵
   1. Li KR,
   2. Avecillas-Chasin J,
   3. Nguyen TD, et al

   . Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease. J Neuroimaging 2022;32:363–71 doi:10.1111/jon.12957 pmid:34904328

   CrossRefPubMed
6. 6.↵
   1. Aggarwal M,
   2. Li X,
   3. Gröhn O, et al

   . Nuclei-specific deposits of iron and calcium in the rat thalamus after status epilepticus revealed with quantitative susceptibility mapping (QSM). J Magn Reson Imaging 2018;47:554–64 doi:10.1002/jmri.25777 pmid:28580758

   CrossRefPubMed
7. 7.↵
   1. Kang JJ,
   2. Chen Y,
   3. Xu GD, et al

   . Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson’s disease and assessing cognitive impairment. Eur Radiol 2022;32:6992–7003 doi:10.1007/s00330-022-08790-8 pmid:35461376

   CrossRefPubMed
8. 8.↵
   1. Tsai YS,
   2. Chen JS,
   3. Wang CK, et al

   . Quantitative assessment of iron in heart and liver phantoms using dual-energy computed tomography. Exp Ther Med 2014;8:907–12 doi:10.3892/etm.2014.1813 pmid:25120622

   CrossRefPubMed
9. 9.↵
   1. Luo XF,
   2. Yang Y,
   3. Yan J, et al

   . Virtual iron concentration imaging based on dual-energy CT for noninvasive quantification and grading of liver iron content: an iron overload rabbit model study. Eur Radiol 2015;25:2657–64 doi:10.1007/s00330-015-3693-4 pmid:25773943

   CrossRefPubMed
10. 10.↵
    1. Ibrahim EH,
    2. Bowman AW

    . Characterization of myocardial iron overload by dual-energy computed tomography compared to T2∗ MRI; a phantom study. Annu Int Conf IEEE Eng Med Biol Soc 2014;2014:5133–36 doi:10.1109/EMBC.2014.6944780 pmid:25571148

    CrossRefPubMed
11. 11.↵
    1. Ma Q,
    2. Hu J,
    3. Yang W, et al

    . Dual-layer detector spectral CT versus magnetic resonance imaging for the assessment of iron overload in myelodysplastic syndromes and aplastic anemia. Jpn J Radiol 2020;38:374–81 doi:10.1007/s11604-020-00921-9 pmid:31989387

    CrossRefPubMed
12. 12.↵
    1. Fischer MA,
    2. Reiner CS,
    3. Raptis D, et al

    . Quantification of liver iron content with CT-added value of dual-energy. Eur Radiol 2011;21:1727–32 doi:10.1007/s00330-011-2119-1 pmid:21472472

    CrossRefPubMed
13. 13.↵
    1. Oshima S,
    2. Fushimi Y,
    3. Okada T, et al

    . Brain MRI with quantitative susceptibility mapping: relationship to CT attenuation values. Radiology 2020;294:600–09 doi:10.1148/radiol.2019182934 pmid:31909699

    CrossRefPubMed
14. 14.↵
    1. Arisaka O,
    2. Ichikawa G,
    3. Imataka G, et al

    . Iron, ketone bodies, and brain development. J Pediatr 2020;222:262–63 doi:10.1016/j.jpeds.2020.03.054 pmid:32340729

    CrossRefPubMed
15. 15.↵
    1. Thirupathi A,
    2. Chang YZ

    . Brain iron metabolism and CNS diseases. Adv Exp Med Biol 2019;1173:1–19 doi:10.1007/978-981-13-9589-5_1 pmid:31456202

    CrossRefPubMed
16. 16.↵
    1. Azuma M,
    2. Hirai T,
    3. Yamada K, et al

    . Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of patients with Parkinson disease measured with quantitative susceptibility mapping. AJNR Am J Neuroradiol 2016;37:782–88 doi:10.3174/ajnr.A4645 pmid:26822728

    Abstract/FREE Full Text
17. 17.↵
    1. Fedeli MP,
    2. Contarino VE,
    3. Siggillino S, et al

    . Iron deposition in parkinsonisms: a quantitative susceptibility mapping study in the deep grey matter. Eur J Radiol 2020;133:109394 doi:10.1016/j.ejrad.2020.109394 pmid:33190103

    CrossRefPubMed
18. 18.↵
    1. Guan JJ,
    2. Feng YQ

    . Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping [in Chinese]. Nan fang yi ke da xue xue bao 2018;38:305–11 doi:10.3969/j.issn.1673-4254.2018.03.10 pmid:29643036

    CrossRefPubMed
19. 19.↵
    1. Li DT,
    2. Hui ES,
    3. Chan Q, et al

    . Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson’s disease with dementia. Neuroimage Clin 2018;20:365–73 doi:10.1016/j.nicl.2018.07.028 pmid:30128274

    CrossRefPubMed
20. 20.↵
    1. Mazzucchi S,
    2. Frosini D,
    3. Costagli M, et al

    . Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin 2019;24:101999 doi:10.1016/j.nicl.2019.101999 pmid:31539801

    CrossRefPubMed
21. 21.↵
    1. Shahmaei V,
    2. Faeghi F,
    3. Mohammdbeigi A, et al

    . Evaluation of iron deposition in brain basal ganglia of patients with Parkinson’s disease using quantitative susceptibility mapping. Eur J Radiol Open 2019;6:169–74 doi:10.1016/j.ejro.2019.04.005 pmid:31065578

    CrossRefPubMed
22. 22.↵
    1. Uchida Y,
    2. Kan H,
    3. Sakurai K, et al

    . Magnetic susceptibility associates with dopaminergic deficits and cognition in Parkinson’s disease. Mov Disord 2020;35:1396–405 doi:10.1002/mds.28077 pmid:32369660

    CrossRefPubMed
23. 23.↵
    1. Luo XF,
    2. Xie XQ,
    3. Cheng S, et al

    . Dual-energy CT for patients suspected of having liver iron overload: can virtual iron content imaging accurately quantify liver iron content? Radiology 2015;277:95–103 doi:10.1148/radiol.2015141856 pmid:25880263

    CrossRefPubMed
24. 24.↵
    1. Hamid S,
    2. Nasir MU,
    3. So A, et al

    . Clinical applications of dual-energy CT. Korean J Radiol 2021;22:970–82 doi:10.3348/kjr.2020.0996 pmid:33856133

    CrossRefPubMed
25. 25.↵
    1. Naruto N,
    2. Itoh T,
    3. Noguchi K

    . Dual energy computed tomography for the head. Jpn J Radiol 2018;36:69–80 doi:10.1007/s11604-017-0701-4 pmid:29119457

    CrossRefPubMed
26. 26.↵
    1. Guan X,
    2. Xuan M,
    3. Gu Q, et al

    . Regionally progressive accumulation of iron in Parkinson’s disease as measured by quantitative susceptibility mapping. NMR Biomed 2017;30:e3489 doi:10.1002/nbm.3489 pmid:26853890

    CrossRefPubMed
27. 27.↵
    1. Chen Q,
    2. Chen Y,
    3. Zhang Y, et al

    . Iron deposition in Parkinson's disease by quantitative susceptibility mapping. BMC Neurosci 2019;20:23 doi:10.1186/s12868-019-0505-9 pmid:31117957

    CrossRefPubMed
28. 28.↵
    1. Lewis MM,
    2. Du G,
    3. Kidacki M, et al

    . Higher iron in the red nucleus marks Parkinson’s dyskinesia. Neurobiol Aging 2013;34:1497–503 doi:10.1016/j.neurobiolaging.2012.10.025 pmid:23177595

    CrossRefPubMed
29. 29.↵
    1. Jaggi S,
    2. Khandelwal N,
    3. Sahni D, et al

    . In vitro study of iron deposition in normal human brains: an Indian scenario. Clin Anat 2018;31:275–81 doi:10.1002/ca.22989 pmid:28940799

    CrossRefPubMed
30. 30.↵
    1. Jang J,
    2. Nam Y,
    3. Jung SW, et al

    . Paradoxical paramagnetic calcifications in the globus pallidus: an ex vivo MR investigation and histological validation study. NMR Biomed 2021;34:e4571 doi:10.1002/nbm.4571 pmid:34129267

    CrossRefPubMed
31. 31.↵
    1. De Barros A,
    2. Arribarat G,
    3. Lotterie JA, et al

    . Iron distribution in the lentiform nucleus: a post-mortem MRI and histology study. Brain Struct Funct 2021;226:351–64 doi:10.1007/s00429-020-02175-7 pmid:33389044

    CrossRefPubMed
32. 32.↵
    1. Dimov AV,
    2. Liu Z,
    3. Spincemaille P, et al

    . Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data. Magn Reson Med 2018;79:121–28 doi:10.1002/mrm.26648 pmid:28261863

    CrossRefPubMed
33. 33.↵
    1. Chen J,
    2. Cai T,
    3. Li Y, et al

    . Different iron deposition patterns in Parkinson’s disease subtypes: a quantitative susceptibility mapping study. Quant Imaging Med Surg 2020;10:2168–76 doi:10.21037/qims-20-285 pmid:33139996

    CrossRefPubMed
34. 34.↵
    1. Guan X,
    2. Bai X,
    3. Zhou C, et al

    . Serum ceruloplasmin depletion is associated with magnetic resonance evidence of widespread accumulation of brain iron in Parkinson’s disease. J Magn Reson Imaging 2021;54:1098–106 doi:10.1002/jmri.27680 pmid:33949744

    CrossRefPubMed